Renescience A/S: Financial statements 2025
CVR: 31846803
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Renescience A/S (CVR 31846803) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. That is a decrease of 99.8% compared with the year before. The profit margin was -2,399,700%. Equity in the 2025 report amounted to DKK 73,470,000. The solvency ratio was 90.4%. The company had 1,000 employees in the financial year.
- Revenue
- DKK 21,000
- Gross Profit
- DKK -5,425,000
- Profit/Loss
- DKK -503,937,000
- Equity
- DKK 73,470,000
- Total Assets
- DKK 81,310,000
- Employees
- 1,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 21 t. | -5.4 mio. | -503.9 mio. | 73.5 mio. | 1000 |
| 2024 | 10.8 mio. | -15.4 mio. | -23.9 mio. | 7.4 mio. | 1000 |
| 2023 | 10.4 mio. | -13.5 mio. | -194.6 mio. | -11.7 mio. | 0 |
| 2022 | 10.8 mio. | -10.9 mio. | -13.3 mio. | 183 mio. | 0 |
| 2021 | 8 mio. | -11.4 mio. | -8.3 mio. | 22.8 mio. | - |
Official annual report
How creditworthy is Renescience A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Renescience A/S has published its annual report for 2024. Revenue came to DKK 10,836,000, and the net result was DKK -23,904,000.
As of February 27, 2025, Ole Thomsen has joined the board of directors of Renescience A/S.
As of February 27, 2025, Jens Grymer has joined the board of directors of Renescience A/S.
As of February 27, 2025, Mikael Brandt has left the board of directors of Renescience A/S.
As of February 26, 2025, Ole Thomsen has left the board of directors of Renescience A/S.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RENESCIENCE A/S and DE S&D NR. 1 2008 A/S. The management consists of Thomas Søndergaard Lyse. The board consists of Ole Thomsen (chair), Jens Grymer and Thomas Søndergaard Lyse. The company is owned by Ørsted New Bio Solutions Holding A/S. According to the 2025 annual report, the company had an average of 1,000 employees. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity in the 2025 report amounted to DKK 73,470,000.